XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Total
Balances at Jan. 01, 2021 $ 122 $ 149,014 $ (488) $ 20,516 $ 169,164
Balances (in shares) at Jan. 01, 2021 12,160        
Increase (Decrease) in Stockholders' Equity          
Shares of common stock issued in connection with employee stock purchase plan $ 1 1,384     1,385
Shares of common stock issued in connection with employee stock purchase plan (in shares) 66        
Shares of common stock issued in connection with incentive stock plan   527     527
Shares of common stock issued in connection with incentive stock plan (in shares) 27        
Shares used to pay taxes on stock grants   (12)     (12)
Issuance of restricted stock award and units $ 2 (3)     (1)
Issuance of restricted stock award and units (in shares) 255        
Stock-based compensation expense   4,206     4,206
Net income (loss)       (3,766) (3,766)
Net unrealized gain on derivative contracts     128   128
Balances at Apr. 02, 2021 $ 125 155,116 (360) 16,750 171,631
Balances (in shares) at Apr. 02, 2021 12,508        
Balances at Jan. 01, 2021 $ 122 149,014 (488) 20,516 169,164
Balances (in shares) at Jan. 01, 2021 12,160        
Increase (Decrease) in Stockholders' Equity          
Net income (loss)         (7,527)
Balances at Oct. 01, 2021 $ 128 164,642 (145) 12,989 177,614
Balances (in shares) at Oct. 01, 2021 12,789        
Balances at Apr. 02, 2021 $ 125 155,116 (360) 16,750 171,631
Balances (in shares) at Apr. 02, 2021 12,508        
Increase (Decrease) in Stockholders' Equity          
Shares of common stock issued in connection with incentive stock plan $ 1 850     851
Shares of common stock issued in connection with incentive stock plan (in shares) 77        
Shares used to pay taxes on stock grants $ (1) (3,104)     (3,105)
Shares used to pay taxes on stock grants (in shares) (79)        
Issuance of restricted stock award and units $ 2 (2)      
Issuance of restricted stock award and units (in shares) 207        
Stock-based compensation expense   5,933     5,933
Net income (loss)       (4,601) (4,601)
Net unrealized gain on derivative contracts     104   104
Balances at Jul. 02, 2021 $ 127 158,793 (256) 12,149 170,813
Balances (in shares) at Jul. 02, 2021 12,713        
Increase (Decrease) in Stockholders' Equity          
Shares of common stock issued in connection with employee stock purchase plan $ 1 1,270     1,271
Shares of common stock issued in connection with employee stock purchase plan (in shares) 40        
Shares of common stock issued in connection with incentive stock plan   369     369
Shares of common stock issued in connection with incentive stock plan (in shares) 35        
Issuance of restricted stock award and units (in shares) 1        
Stock-based compensation expense   4,210     4,210
Net income (loss)       840 840
Net unrealized gain on derivative contracts     111   111
Balances at Oct. 01, 2021 $ 128 164,642 (145) 12,989 177,614
Balances (in shares) at Oct. 01, 2021 12,789        
Balances at Dec. 31, 2021 $ 128 167,032 (38) 12,099 $ 179,221
Balances (in shares) at Dec. 31, 2021 12,804       12,804
Increase (Decrease) in Stockholders' Equity          
Shares of common stock issued in connection with employee stock purchase plan $ 1 1,560     $ 1,561
Shares of common stock issued in connection with employee stock purchase plan (in shares) 52        
Shares of common stock issued in connection with incentive stock plan   23     23
Shares of common stock issued in connection with incentive stock plan (in shares) 4        
Shares used to pay taxes on stock grants   (837)     (837)
Shares used to pay taxes on stock grants (in shares) (27)        
Issuance of restricted stock award and units $ 3 (3)      
Issuance of restricted stock award and units (in shares) 373        
Stock-based compensation expense   3,305     3,305
Net income (loss)       (3,773) (3,773)
Net unrealized gain on derivative contracts     38   38
Balances at Apr. 01, 2022 $ 132 171,080   8,326 179,538
Balances (in shares) at Apr. 01, 2022 13,206        
Balances at Dec. 31, 2021 $ 128 167,032 $ (38) 12,099 $ 179,221
Balances (in shares) at Dec. 31, 2021 12,804       12,804
Increase (Decrease) in Stockholders' Equity          
Net income (loss)         $ (8,023)
Balances at Sep. 30, 2022 $ 133 176,002   4,076 $ 180,211
Balances (in shares) at Sep. 30, 2022 13,297       13,297
Balances at Apr. 01, 2022 $ 132 171,080   8,326 $ 179,538
Balances (in shares) at Apr. 01, 2022 13,206        
Increase (Decrease) in Stockholders' Equity          
Shares used to pay taxes on stock grants   (116)     (116)
Shares used to pay taxes on stock grants (in shares) (5)        
Issuance of restricted stock award and units (in shares) 14        
Stock-based compensation expense   1,714     1,714
Net income (loss)       (4,326) (4,326)
Balances at Jul. 01, 2022 $ 132 172,678   4,000 176,810
Balances (in shares) at Jul. 01, 2022 13,215        
Increase (Decrease) in Stockholders' Equity          
Shares of common stock issued in connection with employee stock purchase plan $ 1 1,475     1,476
Shares of common stock issued in connection with employee stock purchase plan (in shares) 63        
Shares of common stock issued in connection with incentive stock plan   247     247
Shares of common stock issued in connection with incentive stock plan (in shares) 29        
Shares used to pay taxes on stock grants   (5)     (5)
Issuance of restricted stock award and units (in shares) (10)        
Stock-based compensation expense   1,607     1,607
Net income (loss)       76 76
Balances at Sep. 30, 2022 $ 133 $ 176,002   $ 4,076 $ 180,211
Balances (in shares) at Sep. 30, 2022 13,297       13,297